CompoAtlas

Hong Ji Tang Qianliexin Jiaonang

Hong Ji Tang Qianliexin Jiaonang, NPN 80142836: natural health product licensed in Canada. Medicinal ingredients: Melia azedarach, Lycium barbarum, Prunus persica, Salvia miltiorrhiza.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Melia azedarach

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated
Lycium barbarum

Source : Lycium barbarum - Fruit

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated
Prunus persica

Source : Prunus davidiana - Graine

Extract : Matériel brut sec

Extraction ratio : 5.854:1

Dry plant equivalent : 84.3 mg

14.4 mgNot calculated
Salvia miltiorrhiza

Source : Salvia miltiorrhiza - racine et rhizome

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated
Carthamus tinctorius

Source : Carthamus tinctorius - Fleur

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated
Vaccaria hispanica subsp. hispanica

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated
Lycopus lucidus var. hirtus

Extract : Matériel brut sec

Extraction ratio : 5.546:1

Dry plant equivalent : 84.3 mg

15.2 mgNot calculated

Non-medicinal ingredients

Dioxyde de titane, Bleu brilliant FCF, Tartrazine, Gélatine

PopulationAgeQuantity per servingFrequency
Hommesminimum: 18 yearsminimum: 4 Capsule ; maximum: 6 Capsule3 Tous les jours

Uses authorised in Canada

Combination of Traditional Chinese Medicine Ingredients. Used in Traditional Chinese Medicine to invigorate blood and dissolve stasis, clear heat, benefit dampness and relieve pain caused by mild to moderate prostatitis and benign prostatic hyperplasia. Used in Traditional Chinese Medicine to help relieve the urologic symptoms of weak urine flow, incomplete voiding, dripping, mild pain and frequent daytime and night time urination.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Hong Ji Tang Prostate Capsule, Hong Ji Tang Qianliexin Capsule, Qianliexin Capsule, Qianliexin Jiaonang
Licence holder
ShanDong Hong JI Tang Pharmaceutical Co. Ltd.
NPN or DIN-HM
80142836
Status
Active licence
Licence date
22 July 2025
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Traditionnelle

Source

Official Health Canada record, licence 80142836

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Hong Ji Tang Qianliexin Jiaonang (ShanDong Hong JI Tang Pharmaceutical Co. Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80142836-hong-ji-tang-qianliexin-jiaonang, updated 22 July 2025.

Enter to analyse, Shift+Enter for a new line